Testing for Pancreatic Cancer
March 7, 2022
Introducing the IMMray® PanCan-d test
Pancreatic cancer is often viewed as a death sentence, primarily because the majority of patients are diagnosed with late-stage disease when surgery is not possible. But if you can detect it early, in stage I or even II, the five-year survival rate improves drastically.
Immunovia’s mission is to improve early detection rates of pancreatic cancer to allow for more and better treatment options. By educating individuals and primary care practitioners about the IMMray® PanCan-d test, they hope to achieve their goal.
The IMMray® PanCan-d test is the first and only blood test dedicated to the early detection of pancreatic cancer. For many, this test signifies hope in a disease that has not provided much hope to people for a long time.
PROMOTED
NeurAxis is dedicated to making sure those who need IB-Stim have access to this safe and effective non-drug alternative for Functional Abdominal Pain due to Irritable Bowel Syndrome in patients aged 11-18 years old.
PROMOTED
Solution for functional abdominal pain due to IBS in teenagers, and professional childcare services at Alvey’s Education.
PROMOTED
The annual Country Music Awards show took place last night at the Moody Center in Austin Texas. The award show aired live on CBS and streamed on Paramount+. Kelsea Ballerini hosted the show and country music’s biggest stars attended. The CMT Music Awards had first-time nominees including Amber Riley, Ashley Cooke, Bret Michaels, Chayce Beckham, Hozier, Koe Wetzel, Stephen […]
Comments